
Ocuphire Pharma and Viatris developed the drug together for the reversal of pharmacologically-induced mydriasis (RM) produced by adrenergic agonist or parasympatholytic agents.

Ocuphire Pharma and Viatris developed the drug together for the reversal of pharmacologically-induced mydriasis (RM) produced by adrenergic agonist or parasympatholytic agents.

Luis Rojas, OD, shares his tips and tricks for getting the best fit for multifocal contact lenses, as well as how to leverage custom fittings as a service as a marketing tool.

AAOMC is focusing on new membership growth, diversity, and how they can continue to move the needle in myopia management.

Lotilaner ophthalmic solution 0.25% (Xdemvy) was approved by the FDA in July, making it the first and only approved treatment for Demodex blepharitis.

The AOA joins several industry leaders in taking the pledge to increase opportunities for Black optometrists and students


The 2023 CRU Eye Symposium in Napa Valley brings exciting presentation topics, including the retina and genetic testing.

Dr Selina McGee, OD, FAAO, Dipl ABO, met with Optometry Times to discuss the recent FDA approval of XDEMVY, a treatment for Demodex blepharitis, from Tarsus Pharmaceuticals.

Hear from A. Paul Chous, OD, MA, FAAO, and what to look forward to during the 2023 EyeCon meeting December 1-2 in Sanibel Harbour, FL.

CRU 2023 will cover a host of topics, including a co-led presentation by Drs Deborah Jacobs and Melissa Barnett on the latest advancements in the contact lens field.

Opthea’s lead biologic drug candidate OPT-302, which is under investigation for the treatment of wet AMD, received nonproprietary drug name sozinibercept, which is a critical step in the FDA approval process.

Diana Canto-Sims, OD, sat down with Optometry Times®' assistant managing editor Emily Kaiser to talk about her role on the founding board of Latinos en Optometry (LEO).

Lina T Arango, OD, sat down with Optometry Times®' assistant managing editor Emily Kaiser to talk about her role on the founding board of Latinos en Optometry (LEO).

Learn about the second annual CRU Eye Symposium, the intentions behind the meeting, and what to expect.

Essence Johnson, OD, FAAO, addressed the "State of optometry," at NOA 2023 in Fort Lauderdale, Florida.

At NOA 2023 in Fort Lauderdale, Florida, Rhea Magee, OD, presented a pediatric patient case as part of the Resident Grand Rounds.

Immediate past president of AOSA Easy Anyama speaks on the latest initiatives of the student organization at NOA 2023 in Fort Lauderdale, Florida.

Isa Prude, president of NOSA, speaks on the Diversifying Optometry Initiative at NOA 2023.

At NOA 2023, Monique Barbour, MD, caught up with Optometry Times to tell us more about her presentation on the latest and greatest in glaucoma.

Jacobi Cleaver, OD, FAAO, caught up with Optometry Times to talk about his presentation on squamous cell carcinoma of the conjunctiva, which he discussed at the National Optometric Association in Fort Lauderdale, Florida.

At NOA 2023, Brianna Rhue, OD, FAAO, FSLS, caught up with Optometry Times to tell us more about the now and how of myopia management.

Brianna Rhue, OD, FAAO, FSLS, met with Optometry Times to talk about her presentation titled, "Myopia- How and Now," which she will be sharing at the National Optometric Association in Fort Lauderdale, Florida.

Jacobi Cleaver, OD, FAAO, caught up with Optometry Times to talk about his presentation on neurotrophic keratits, which he discussed at the National Optometric Association in Fort Lauderdale, Florida.

Essence Johnson, OD, FAAO, hosts an insightful conversation about the Black eye care experience at NOA 2023 Convention in Fort Lauderdale, Florida.

At NOA 2023, Brianna Rhue, OD, FAAO, spoke to us about Dr. Contact Lens, a practice management tool that allows patients to reorder lenses online, sends reminders for followup appointments, and more.

Nwamaka Ngoddy, OD, founder of Anwuli Eye Wear, gives us a brief look into her inclusive line of frames during NOA 2023.

Pierce Kenworthy, OD, gives the crowd at NOA 2023 an in-depth look at the cornea and all the dangers that could befall it. He details what clinicians should look for and when to refer to an ophthalmologist for surgery.

Pierce Kenworthy, OD, met with Optometry Times to talk about his course titled, "Eyelid Conjunctive Growths & Degenerations: From Benign to Terrifying," which he will be presenting at the National Optometric Association 2023 annual convention in Fort Lauderdale, Florida.

The company has entered a definitive agreement with Novartis to acquire Xiidra (liftegrast ophthalmic solution 5%), representing a significant opportunity for growth in prescription dry eye.

Marjorie Rah, OD, PhD, FAAO, shares brief highlights from her 2023 AOA ePoster, "Clinical performance of unique preservative-free contact lens lubricating and rewetting drop."